Smartphone-Based Brunnstrom Stage Classification of Hemiparetic Gait via Skeleton-Attention-LSTM-Inception Network.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 42497051.
- Also identified by DOI 10.1109/TBME.2026.3713910.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The accurate assessment of hemiparetic gait after stroke was essential for understanding the extent of motor impairment and for guiding rehabilitation efforts. In this study, a kinematic based deep learning classifier was proposed to eliminate inter-rater variability in lower-limb Brunnstrom Recovery Stage (BRS) assessment and enable quantitative longitudinal tracking of post-stroke motor recovery. Forty healthy adults and fifty-one hemiparetic stroke patients (BRS III-VI) were recruited, and video recorded kinematic data were collected during their standardized walking tasks. Anatomical keypoint coordinates were extracted from the video recordings via advanced pose estimation algorithms for fine-grained kinematic analysis. A novel hybrid Skeleton-Attention long short-term memory (LSTM)-Inception architecture was then developed for BRS stage classification using three-dimensional keypoint coordinate data. The architecture synergistically integrated LSTM layers for temporal sequence modeling with Inception modules for multi-scale spatial feature extraction. The proposed model's performance was systematically compared against conventional deep learning benchmarks, including convolutional neural networks (CNNs) and coupled LSTM-CNN hybrid models. Our experimental results revealed that the proposed framework achieved superior classification accuracy compared to alternatives (97.3% vs. 87.7-95.2%). These findings demonstrated the clinical potential of deep learning-driven motion analytics to eliminate assessment subjectivity in BRS staging. This approach is expected to facilitate quantitative longitudinal monitoring of neurorehabilitation progress and support the development of data-driven personalized therapeutic strategies, potentially reducing reliance on clinician expertise.